Events

Browse Events My events

Blog

Browse articles

Market

Latest Products

More

Forum Explore Popular Posts Games Jobs Offers Fundings
Events Market Blog See all
richardwilliam93
richardwilliam93  created a new article
9 w

Yamo Pharma doses first subject in Phase II autism spectrum disorder trial | #autism Clinical Trials Market

Yamo Pharma doses first subject in Phase II autism spectrum disorder trial
News and Politics

Yamo Pharma doses first subject in Phase II autism spectrum disorder trial

The leading companies in the autism clinical trials market are Otsuka Holdings Co Ltd, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, autism Speaks Inc, Johnson & Johnson, Seaside Therapeutics LLC (Inactive), Bristol-Myers Squibb Co, Curemark LLC, Eli Lilly and Co, and F
Latest Products See all